{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:Q08495",
      "entity_text" : "DMT",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:3822",
      "entity_text" : "ketanserin",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Next we found that co-treatment with ketanserin, a selective 5-HT2A antagonist, completely abrogated the ability of DMT, LSD, and DOI to promote both neuritogenesis and spinogenesis (XREF_FIG).",
  "reading_complete" : "2020-08-08T20:03:27Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T20:02:00Z",
  "trigger" : "abrogated",
  "evidence" : [ "ketanserin, a selective 5-HT2A antagonist, completely abrogated the ability of DMT" ],
  "pmc_id" : "6082376",
  "score" : 0
}